Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

NCT05220917 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

781430

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Events
Type2 Diabetes
Renal Disease

Interventions

DRUG: SGLT2 inhibitor
DRUG: DPP-4 inhibitor
DRUG: GLP-1RA
DRUG: 2nd generation SU

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]